[O1–05–01]: CLINICAL VALIDATION OF DIAGNOSING ALZHEIMER's DISEASE BY ASSAYING PLASMA AMYLOIDS AND TAU PROTEIN VIA IMMUNOMAGNETIC REDUCTION. (1st July 2017)